NCT00426114

Brief Summary

Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.

Trial Health

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 24, 2007

Completed
Last Updated

July 7, 2021

Status Verified

July 1, 2021

First QC Date

January 23, 2007

Last Update Submit

July 5, 2021

Conditions

Peritoneal Dialysis

Outcome Measures

Primary Outcomes (2)

  • Haemodynamic parameters

  • Glycemia

Interventions

Administration of an IV glucose-injectionDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years old
  • Stable clinical condition
  • Either peritoneal dialysis (at least one month) either matched healthy subject

You may not qualify if:

  • Heart Failure
  • Diabetes requiring insulin treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

Study Officials

  • Wim Van Biesen, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2007

First Posted

January 24, 2007

Last Updated

July 7, 2021

Record last verified: 2021-07